GLENWOOD, Ill., April 15, 2015 /PRNewswire/ -- Landauer, Inc.
(NYSE: LDR), a recognized leader in personal and environmental
radiation measurement and monitoring, outsourced medical physics
services and medical consumable accessories, today announced the
appointment of Jeffrey Bailey as an
Independent Director, effective April 15,
2015. The Landauer Board of Directors now consists of seven
individuals, six of whom are considered independent.
"Jeff's insights and experiences as a provider of products and
services to the healthcare market will be an excellent addition to
our current team," said Robert
Cronin, Chairman of the Board of Directors at Landauer.
"With strong functional experience in operations, financial
management, sales and marketing, Jeff's background includes deep
knowledge and understanding of the issues and opportunities created
by the new requirements of The Joint Commission. We look forward to
benefiting from Jeff's contributions on our Board for many years to
come."
"I am honored to join the Board of Directors and am excited to
be working with the Landauer team," said Jeff Bailey. "Landauer has an excellent
reputation in its field and is poised to build on its history of
innovation and market leadership. I look forward to contributing to
its future success as the company extends its role as a pioneer in
the industry."
Mr. Bailey has nearly 30 years of experience in the
pharmaceutical industry with a broad range of functional leadership
experience. Since 2013, he has been the President and Chief
Executive Officer and a Director of Lantheus Medical Imaging, Inc.,
a global leader in providing diagnostic imaging agents, primarily
used for the diagnosis of cardiovascular diseases. Prior
experiences include Chief Operating Officer of Fougera
Pharmaceuticals (formerly Nycomed US), Chief Commercial Officer of
King-Pfizer Pharmaceuticals, President and General Manager of
Novartis NorthWest Operating Unit and various executive, commercial
and manufacturing roles within the Johnson & Johnson family of
companies.
About Landauer
Landauer is a leading global provider of technical and
analytical services to determine occupational and environmental
radiation exposure, the leading domestic provider of outsourced
medical physics services, as well as a provider of high quality
medical accessories used in radiology, radiation therapy, and image
guided surgery procedures. For more than 50 years, the
Company has provided complete radiation dosimetry services to
hospitals, medical and dental offices, universities, national
laboratories, nuclear facilities and other industries in which
radiation poses a potential threat to employees. Landauer's
services include the manufacture of various types of radiation
detection monitors, the distribution and collection of the monitors
to and from customers, and the analysis and reporting of exposure
findings. The Company provides its dosimetry services to
approximately 1.8 million individuals globally. In addition,
through its Medical Physics segment, the Company provides
therapeutic and imaging physics services to the medical physics
community. Through its Medical Products segment, the Company
provides medical consumable accessories used in radiology,
radiation therapy, and image guided surgery procedures. For
information about Landauer, please visit their website at
http://www.landauer.com.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/landauer-inc-appoints-jeffrey-bailey-as-independent-director-300065925.html
SOURCE Landauer, Inc.